Desloratadine

CAS Number100643-71-8
Molecular FormulaC19H19ClN2
Molecular Weight310.8
InChI KeyJAUOIFJMECXRGI-UHFFFAOYSA-N
LogP4.5
Synonyms
  • Desloratadine
  • 100643-71-8
  • Clarinex
  • Descarboethoxyloratadine
  • Desloratidine
  • Aerius
  • Neoclarityn
  • Azomyr
  • Sch-34117
  • Denosin
  • Allex
  • Opulis
  • Sch 34117
  • 8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
  • Desloratadine Actavis
  • Dasselta
  • 8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
  • Desloratadine teva
  • 5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-
  • Desloratadina
  • NSC-759824
  • DTXSID1044196
  • FVF865388R
  • 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine
  • DESLORATADINE RATIOPHARM
  • DTXCID9024196
  • CHEBI:291342
  • 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
  • 13-chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene
  • 5H-Benzo(5,6)cyclohepta(1,2-b)pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-
  • DESLORATADINE TEVA (AUTHORIZED: RHINITIS, URTICARIA)
  • DESLORATADINE ACTAVIS (AUTHORIZED: RHINITIS, URTICARIA)
  • DESLORATADINE RATIOPHARM (AUTHORIZED: RHINITIS, URTICARIA)
  • desloratadinum
  • Midetorin
  • 8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridine
  • 8-chloro-11-piperidin-4-ylidene-5,6-dihydrobenzo(1,2)cyclohepta(2,4-b)pyridine
  • 8-chloro-11-piperidin-4-ylidene-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridine
  • 8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridine
  • 13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3,5,7,12,14-hexaene
  • 13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaene
  • 13-chloro-2-piperidin-4-ylidene-4-azatricyclo(9.4.0.03,8)pentadeca-1(11),3(8),4,6,12,14-hexaene
  • RefChem:57884
  • R06AX27
  • 13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo(9.4.0.03,8)pentadeca-1(11),3(8),4,6,12,14-hexaene
  • MFCD00871949
  • Descarboethoxyoratidine
  • CHEMBL1172
  • MLS000559042
  • NSC675447
  • NCGC00159325-02
  • SMR000149358
  • Desloratadine [USAN]
  • Clarinex RediTabs
  • 8-chloro-6,11-dihydro-11-(4-piperdinylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
  • 13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaene
  • Desalex
  • Clarinex (TN)
  • 8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine (Descarboethoxyloratadine; Desloratadine)
  • 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDINYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE-D5
  • CAS-100643-71-8
  • SR-01000668962
  • Loratadine EP Impurity D
  • UNII-FVF865388R
  • NeoClarityn;
  • Claramax;
  • Clarinex;
  • Desloratadine [USAN:INN:BAN]
  • Desloratadine-d7
  • 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta(1,2-b]pyridin-11-ylidene)-piperidine
  • 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine
  • 4-{8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene}-piperidine
  • 4-{8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene}piperidine
  • Desloratadine CRS
  • Loratadine metabolite
  • MK-4117
  • CPD000149358
  • Desloratadine (Standard)
  • Opera_ID_1891
  • DESLORATADINE [MI]
  • DESLORATADINE [INN]
  • DESLORATADINE [JAN]
  • SCHEMBL4425
  • DESLORATADINE [VANDF]
  • MLS000759406
  • MLS001201801
  • MLS001424247
  • DESLORATADINE [MART.]
  • DESLORATADINE [USP-RS]
  • DESLORATADINE [WHO-DD]
  • Desloratadine (JAN/USP/INN)
  • GTPL7157
  • orb1305363
  • DESLORATADINE [EMA EPAR]
  • SCHEMBL29371361
  • SCHEMBL29390260
  • HY-B0539R
  • Desloratadine - Bio-X trade mark
  • GLXC-03578
  • HMS2052H05
  • HMS2090C06
  • HMS2093F19
  • HMS3394H05
  • HMS3652O15
  • HMS3715J15
  • HMS3885C18
  • HMS5082N15
  • Pharmakon1600-01505393
  • DESLORATADINE [ORANGE BOOK]
  • ALBB-027276
  • ARD10141
  • Desloratadine for system suitability
  • HY-B0539
  • MSK10141
  • VQB71934
  • VWC02482
  • DESLORATADINE [EP MONOGRAPH]
  • Tox21_111574
  • BBL010777
  • BDBM50073179
  • DESLORATADINE [USP MONOGRAPH]
  • EBC-06071
  • NSC759824
  • s4012
  • STK586537
  • AKOS000280921
  • Tox21_111574_1
  • AC-1279
  • CCG-101162
  • DB00967
  • KS-1048
  • NC00412
  • NSC 759824
  • NSC-675447
  • SB17503
  • 8-chloro-6,11-dihydro-11-(4-piperdinylidene)- 5H-benzo[5,6]cyclohepta[1,2-b]pyridine
  • Desloratadine for system suitability CRS
  • Desloratadine; Loratadine EP Impurity D
  • CLARINEX-D COMPONENT DESLORATADINE
  • Desloratadine, powder, >=98% (HPLC)
  • NCGC00159325-03
  • NCGC00159325-04
  • NCGC00159325-05
  • BD164361
  • SY053082
  • SBI-0206828.P001
  • LORATADINE IMPURITY D [EP IMPURITY]
  • D3787
  • NS00008826
  • SW197792-3
  • D03693
  • H11943
  • AB00456701-11
  • AB00456701-13
  • AB00456701_14
  • AB00456701_15
  • EN300-1589139
  • F375848
  • L001025
  • Q418060
  • RUPATADINE FUMARATE IMPURITY B [EP IMPURITY]
  • SR-01000668962-4
  • SR-01000668962-5
  • SR-01000668962-8
  • BRD-K82357231-001-13-4
  • BRD-K82357231-001-17-5
  • BRD-K82357231-001-18-3
  • BRD-K82357231-001-19-1
  • Z2235801903
  • Desloratadine, European Pharmacopoeia (EP) Reference Standard
  • Desloratadine, United States Pharmacopeia (USP) Reference Standard
  • 4-(8-chloro-5,6-dihydro-11 H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine
  • 4-(8-chloro-5,6-dihydro-11H-benzo-[5,6]cyclohepta(1,2-b]pyridin-11-ylidene)-piperidine
  • 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta [1,2-b]pyridin-11-ylidene) piperidine
  • 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene) piperidine
  • 8-chloro-11-(4-piperidinylidene)-6,11-dihydro-5H- benzo[4,5]cyclohepta[2,1-b]pyridine
  • 8-chloro-11-(4-piperidyliden)-6,11-dihydro-5H-benzo[5,6]cyclohepta [1,2-b]pyridine
  • 8-chloro-11-(4-piperidyliden)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
  • 8-chloro-11-(4-piperidylidene)-6,11-dihydro-5h-benzo[5.6]cyclohepta[1,2-b]pyridine
  • 8-Chloro-5,6-dihydro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine)
  • 8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H- benzo[5,6]cyclohepta[1,2,b]pyridine
  • 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
  • Desloratadine for system suitability, European Pharmacopoeia (EP) Reference Standard
  • Desloratidine, Pharmaceutical Secondary Standard; Certified Reference Material
  • 13-chloro-2-(4-piperidylidene)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene
  • 13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaene
  • 8-CHLORO-11-(4-PIPERIDYLIDENE)-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE

Applications:

Uv-Vis Spectrum of Desloratadine

March 26, 2026

Access the UV-Vis Spectrum SIELC Library

If you are looking for optimized HPLC method to analyze Desloratadine check our HPLC Applications library

For optimal results in HPLC analysis, it is recommended to measure absorbance at a wavelength that matches the absorption maximum of the compound(s) being analyzed. The UV spectrum shown can assist in selecting an appropriate wavelength for your analysis. Please note that certain mobile phases and buffers may block wavelengths below 230 nm, rendering absorbance measurement at these wavelengths ineffective. If detection below 230 nm is required, it is recommended to use acetonitrile and water as low UV-transparent mobile phases, with phosphoric acid and its salts, sulfuric acid, and TFA as buffers.
For some compounds, the UV-Vis Spectrum is affected by the pH of the mobile phase. The compound was dissolved in Acetonitrile and Methanol.

Application Analytes:
Desloratadine
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.